The First Affiliated Hospital with Nanjing Medical University: clinical-trial pipeline
The First Affiliated Hospital with Nanjing Medical University is the sponsor of 563 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 253 are not yet finished and 17 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials253
Phase 2/3 and 326
Countries2
New in 90 days17
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 308 |
| Phase 2 | 146 |
| Phase 4 | 31 |
| Phase 1 | 22 |
| Phase 3 | 21 |
| Early phase 1 | 18 |
| Phase 1/2 | 12 |
| Phase 2/3 | 5 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 208 |
| Recruiting | 145 |
| Not yet recruiting | 97 |
| Completed | 94 |
| Active, not recruiting | 11 |
| Terminated | 7 |
| Withdrawn or not authorised | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 300 |
| Cardiovascular | 100 |
| Gastroenterology and liver | 51 |
| Nephrology and urology | 40 |
| Neurology | 32 |
| Respiratory | 27 |
| Infectious disease and vaccines | 12 |
| Rare and genetic diseases | 12 |
| Immunology and rheumatology | 11 |
| Metabolic and endocrine (diabetes, obesity) | 11 |
| Women's health and obstetrics | 11 |
| Dermatology | 7 |
Countries
| Country | Trials |
|---|---|
| China | 470 |
| Russia | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-22 | New trial posted | Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and… |
| 2026-10-20 | New trial posted | Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCL |
| 2026-10-15 | New trial posted | Fufang Tongluo Decoction as an Adjunct to Aspirin and Atorvastatin for Ischemic Moyamoya… |
| 2026-10-14 | New trial posted | A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonr… |
| 2026-10-14 | New trial posted | Real-World Study of BCL-2 Inhibitor-Based Regimens in Chronic Lymphocytic Leukemia |
| 2026-10-13 | New trial posted | Efficacy and Safety of Intraoperative Radiotherapy Combined With Serplulimab Plus Chemoth… |
| 2026-10-13 | New trial posted | Optimization of Surgical Treatment Pathways for BPH Based on Real-World Data |
| 2026-10-06 | New trial posted | Ear-Vagus Nerve Stimulation and Body Acupuncture for Gut Motility in Elderly ICU Patients |
| 2026-10-02 | New trial posted | The Efficacy and Safety of Winona Barrier Special Cream in Post-acne Erythema a Parallel… |
| 2026-10-01 | New trial posted | Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy |
| 2026-09-30 | New trial posted | HER2-positive Breast Cancer Without Intravenous Neoadjuvant Therapy |
| 2026-09-29 | New trial posted | Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitin… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05461820 | Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease | Phase 4 | Recruiting | China |
| NCT07746245 | The Efficacy of CAPCT in Patients With PTCL | Phase 2 | Not yet recruiting | China |
| NCT06561646 | To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer | Not applicable | Not yet recruiting | China |
| NCT07612670 | A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephal… | Not applicable | Not yet recruiting | China |
| NCT06986512 | Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Im… | Not applicable | Not yet recruiting | China |
| NCT06645535 | The Gut Microbiota and Metabolites in HFpEF | Not applicable | Recruiting | China |
| NCT06929962 | VA Dual Sequential Therapy | Phase 4 | Recruiting | China |
| NCT04964310 | Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-co… | Not applicable | Recruiting | China |
| NCT05572957 | LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB | Not applicable | Active, not recruiting | China |
| NCT07372339 | Comparison of Breast Sensory Recovery Between Conventional and Endoscopic Nipple-Sparing Mastectomy Combined… | Not applicable | Not yet recruiting | |
| NCT07232095 | 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy | Phase 4 | Recruiting | China |
| NCT07195799 | Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL | Phase 2 | Recruiting | China |
| NCT07113496 | RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies | Phase 1 | Not yet recruiting | China |
| NCT06335836 | The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function… | Not applicable | Recruiting | China |
| NCT07148427 | Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Gastric/Gastroesophageal Junction Ad… | Phase 2 | Not yet recruiting | |
| NCT06472479 | LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma | Not applicable | Not yet recruiting | China |
| NCT07628582 | A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell Malignancies | Phase 1 | Not yet recruiting | China |
| NCT06037655 | Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectab… | Phase 2 | Not yet recruiting | |
| NCT07002112 | The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Mal… | Phase 1 | Recruiting | China |
| NCT06656624 | Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequenti… | Phase 2 | Recruiting | China |
| NCT06779318 | Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With… | Phase 4 | Not yet recruiting | China |
| NCT07371247 | Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable L… | Early phase 1 | Recruiting | China |
| NCT07110311 | Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy | Not applicable | Recruiting | China |
| NCT07446452 | Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study | Phase 2 | Recruiting | China |
| NCT07783464 | Heart Rate Variability Changes and Postoperative Delirium After Major Abdominal Surgery | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "The First Affiliated Hospital with Nanjing Medical University clinical trials: 253 open, 26 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/the-first-affiliated-hospital-with-nanjing-medical-universit/, data as of 2026-10-25.